A new doctrine could soon take hold in part of the US war on drugs: psychedelic drugs for active-duty soldiers suffering from PTSD.
In two studies funded by the Department of Defense (DoD), 186 service personnel with PTSD will likely next year undergo multiple sessions of MDMA-assisted therapy.
The deputy under secretary of war for personnel and readiness, Sean O’Keefe, is following the research closely, a January letter shows, and a new group of DoD and Veterans Affairs (VA) department therapists are to begin training in psychedelic-assisted therapy next week ahead of soldier enrollment.
It is hoped guided sessions with the euphoria-inducing drug could, perhaps counterintuitively, help soldiers fight for their country for longer – and that once they leave the military they will not be crippled by traumatic stress.
Pete Hegseth’s controversial plan to screen older soldiers for testosterone deficiencies and offer them more of...
When the ‘“department of government efficiency” was raging unchecked through the federal government in February 2025,...
The US defense secretary, Pete Hegseth, this week ordered an annual testosterone-deficiency screening for active-duty and...
